ALTEOGEN Inc. (KOSDAQ: A196170)
Health Care · Biotechnology · KR
₩241,000.00
-7.13% today · -29.4% 1Y
ALTEOGEN Inc. (KOSDAQ: A196170) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.48B.
Over the last twelve months the share price has lost 29.4%, trading between 194.62K and 437.69K.
Tweenvest scores ALTEOGEN Inc. across four factors: quality 77/100, value 54/100, growth 100/100, dividend 3/100. Its strongest factor is growth.
A196170 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.48B
- Revenue (TTM)
- $164.03M
- P/E
- 92.32
- EPS
- 2,610.42
- Dividend yield
- 0.12%
- Beta (5Y)
- 0.98
- 52-week high
- ₩437,692.31
- 52-week low
- ₩194,615.38
- Avg volume (3M)
- —
- Shares outstanding
- 69.63M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SEHK: 6990 | $13.54B | HK$444.60 | -0.27% |
| Akeso, Inc.SEHK: 9926 | $12.81B | HK$109.10 | +2.15% |
| BridgeBio Pharma, Inc.NasdaqGS: BBIO | $12.78B | $65.35 | +0.48% |
| Halozyme Therapeutics, Inc.NasdaqGS: HALO | $12.53B | $110.42 | +0.53% |
| ImmunityBio, Inc.NasdaqGS: IBRX | $11.14B | $10.51 | +6.05% |
| Madrigal Pharmaceuticals, Inc.NasdaqGS: MDGL | $10.90B | $471.75 | -5.54% |
| Vaxcyte, Inc.NasdaqGS: PCVX | $10.62B | $71.12 | -0.36% |
| BioMarin Pharmaceutical Inc.NasdaqGS: BMRN | $10.61B | $55.34 | +0.99% |
Figures last refreshed Oct 11, 2026.